Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I/IIa Safety and Immunologic Efficacy Trial of Intraperitoneal Induction of CTLs Combined With Alpha-Dendritic Cell Vaccine for Primary Ovarian Cancer

NCT03735589 is registered in ClinicalTrials.gov with Roswell Park Cancer Institute as lead sponsor.

NCT NCT03735589
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03735589 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I/IIa Safety and Immunologic Efficacy Trial of Intraperitoneal Induction of CTLs Combined With Alpha-Dendritic Cell Vaccine for Primary Ovarian Cancer
Lead sponsor
Roswell Park Cancer Institute
Phase
Phase 1/2
Overall status
Withdrawn
Start date
December 15, 2023
Completion date
December 1, 2025
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

stage ii fallopian tube cancer ajcc v8, stage ii ovarian cancer ajcc v8, stage ii primary peritoneal cancer ajcc v8, stage iia fallopian tube cancer ajcc v8, stage iia ovarian cancer ajcc v8, stage iia primary peritoneal cancer ajcc v8, stage iib fallopian tube cancer ajcc v8, stage iib ovarian cancer ajcc v8, stage iib primary peritoneal cancer ajcc v8, stage iii fallopian tube cancer ajcc v8, stage iii ovarian cancer ajcc v8, stage iii primary peritoneal cancer ajcc v8, stage iiia fallopian tube cancer ajcc v8, stage iiia ovarian cancer ajcc v8, stage iiia primary peritoneal cancer ajcc v8, stage iiia1 fallopian tube cancer ajcc v8, stage iiia1 ovarian cancer ajcc v8, stage iiia2 fallopian tube cancer ajcc v8, stage iiia2 ovarian cancer ajcc v8, stage iiib fallopian tube cancer ajcc v8, stage iiib ovarian cancer ajcc v8, stage iiib primary peritoneal cancer ajcc v8, stage iiic fallopian tube cancer ajcc v8, stage iiic ovarian cancer ajcc v8, stage iiic primary peritoneal cancer ajcc v8, stage iv fallopian tube cancer ajcc v8, stage iv ovarian cancer ajcc v8, stage iv primary peritoneal cancer ajcc v8, stage iva fallopian tube cancer ajcc v8, stage iva ovarian cancer ajcc v8, stage iva primary peritoneal cancer ajcc v8, stage ivb fallopian tube cancer ajcc v8, stage ivb ovarian cancer ajcc v8, stage ivb primary peritoneal cancer ajcc v8